WOCKPHARMA2019-07-012019-09-30in-bse-fin:OneOperatingExpenses01Member WOCKPHARMA2019-07-012019-09-30in-bse-fin:OneOperatingExpenses02Member WOCKPHARMA2019-07-012019-09-30in-bse-fin:FourOperatingExpenses01Member WOCKPHARMA2019-07-012019-09-30in-bse-fin:FourOperatingExpenses02Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares WOCKPHARMA 2019-04-01 2020-03-31 2019-10-22 INR Crores Half yearly Single segment Pharmaceuticals 2019-07-01 2019-09-30 Unaudited Consolidated 8021800000.00 -2000000.00 8019800000.00 1478000000.00 1488800000.00 248800000.00 2164600000.00 646400000.00 533600000.00 2165100000.00 8725300000.00 -705500000.00 0.00 -705500000.00 -11500000.00 248400000.00 236900000.00 0.00 -942400000.00 0.00 0.00 0.00 0.00 -942400000.00 -131700000.00 -1074100000.00 -821700000.00 -120700000.00 -935200000.00 -138900000.00 553700000.00 5 -7.42 -7.42 0.00 0.00 -7.42 -7.42 1 For Notes to Consolidated Results please refer the Notes from the Statement of Consolidated Unaudited Results for the quarter and six months ended September 30 2019 as attached which is submitted under Outcome of Board Meeting n n2 ForConsolidated Unaudited Cash Flow Statement for Six months ended September 30, 2019 please refer Statement of Consolidated Unaudited Results for the quarter and six months ended September 30 2019 as attached which is submitted under Outcome of Board Meeting 2019-04-01 2019-09-30 Unaudited Consolidated 16652900000.00 78800000.00 16731700000.00 3175900000.00 3035100000.00 532000000.00 4548600000.00 1355300000.00 1083200000.00 4485700000.00 18215800000.00 -1484100000.00 0.00 -1484100000.00 57200000.00 -230100000.00 -172900000.00 0.00 -1311200000.00 0.00 0.00 0.00 0.00 -1311200000.00 -70200000.00 -1381400000.00 -1271500000.00 -39700000.00 -1332600000.00 -48800000.00 553700000.00 5 -11.49 -11.49 0.00 0.00 -11.49 -11.49 Exchange fluctuatution loss/ (gain), net -44400000.00 Other Expenses 2209500000.00 Exchange fluctuatution loss/ (gain), net 112300000.00 Other Expenses 4373400000.00